Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825857) titled 'Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: University of Texas Southwestern Medical Center
Condition:
Methamphetamine Use Disorder
Intervention:
Drug: Tirzepatide
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 1, 2026
Target Sample Size: 228
Countries of Recruitment:
United States
To know ...